Yeshiva University v. Greenberg

The instant action arises out of a dispute between the parties concerning title to, and the right to commercially distribute, an antibody known as PHF-1 and its cell line. This antibody has the potential for use in diagnosing and treating Alzheimer’s disease. The record indicates that the defendant developed this antibody while employed by the plaintiff as a research associate in the Pathqlogy Department of the plaintiff’s Albert Einstein College of Medicine (hereinafter AECOM). The defendant worked in a laboratory headed by Dr. Peter Davies, who was conducting research relating to…